Rayzebio has a total of 13 patents globally, out of which 4 have been granted. Of these 13 patents, more than 84% patents are active. The United States of America is where Rayzebio has filed the maximum number of patents, followed by Taiwan, Argentina and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Rayzebio.
Rayzebio was founded in 2020. Rayzebio operates as a biotechnology company that provides radiopharmaceutical medicines for cancer. The company uses radioisotopes to create tiny molecule drugs that target tumours.
Do read about some of the most popular patents of Rayzebio which have been covered by us in this article and also you can find Rayzebio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Rayzebio patent portfolio.
How many patents does Rayzebio have?
Rayzebio has a total of 13 patents globally. These patents belong to 5 unique patent families. Out of 13 patents, 11 patents are active.
How Many Patents did Rayzebio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Rayzebio Applications Filed | Rayzebio Patents Granted |
| 2023 | 1 | 3 |
| 2022 | 9 | 1 |
| 2021 | 3 | – |
How many Rayzebio patents are Alive/Dead?
Worldwide Patents
How Many Patents did Rayzebio File in Different Countries?
Countries in which Rayzebio Filed Patents
| Country | Patent |
| United States Of America | 5 |
| Taiwan | 1 |
| Argentina | 1 |
| Europe | 1 |
Where are Research Centers of Rayzebio Patents Located?
The Research Centers of Rayzebio Patents is the United States of America.
Best Rayzebio Patents
US11541134B1, US11497822B1 are the most popular patent in the Rayzebio portfolio. It has received 3 citations so far from companies.
Below is the list of most cited patents of Rayzebio:
| Publication Number | Citation Count |
| US11541134B1 | 3 |
| US11497822B1 | 3 |
| US11707540B2 | 2 |
| WO2022115799A1 | 2 |
What Percentage of Rayzebio US Patent Applications Were Granted?
Rayzebio (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100%.
Below are the key stats of Rayzebio patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Rayzebio?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 2 | 100% |
List of Rayzebio patents
| Rayzebio Patents | Title |
| US11819556B2 | Stabilized Compositions Of Radionuclides And Uses Thereof |
| US11707540B2 | Stabilized Compositions Of Radionuclides And Uses Thereof |
| US11541134B1 | Stabilized Compositions Of Radionuclides And Uses Thereof |
| US11497822B1 | Stabilized Compositions Of Radionuclides And Uses Thereof |
| US20230158179A1 | Radiopharmaceutical Conjugate Compositions And Uses Thereof |
| EP4251639A1 | Radiopharmaceutical Conjugate Compositions And Uses Thereof |
| WO2023191839A9 | Stabilized Compositions Of Radionuclides And Uses Thereof |
| WO2023014988A8 | Conjugates Comprising Covalent Binders For Targeting Intracellular Proteins |
| WO2023014979A9 | Conjugates Comprising Covalent Binders For Targeting Intracellular Kras G12C Proteins |
| AR126667A1 | Stabilized Radioisotope Compositions And Their Uses |
| TW202320865A | Stabilized Compositions Of Radionuclides And Uses Thereof |
| WO2022115799A1 | Radiopharmaceutical Conjugates Targeting Guanylyl Cyclase C, And Compositions And Uses Thereof |
| WO2022115778A1 | Radiopharmaceutical Conjugate Compositions And Uses Thereof |
What are Rayzebio key innovation segments?
What Technologies are Covered by Rayzebio?
The chart below distributes patents filed by Rayzebio